Promising results vs. COVID variants from Moderna, Pfizer vaccines
Moderna's results are preliminary and involve the South African and Brazlian variants. Pfizer's are from real-world data out of Israel on the British variant.
Pfizer
CDC projects covid cases in U.S. will drop
The Centers for Disease Control is now projecting COVID-19 cases and deaths in the U.S. will fall sharply by the end of July. Dr. William Schaffner, a professor of preventive medicine at Vanderbilt University School of Medicine, joined CBSN's Tanya Rivero with more on the president's new goals for vaccinating Americans.
Vaccine access could soon expand to kids
The CDC Advisory Committee on Immunization Practices will hold an emergency meeting next week, as Pfizer prepares to seek authorization to offer its vaccine for kids age 12 to 15. Internal medicine specialist and immunologist Dr. Neeta Ogden joins CBSN to discuss that, plus efforts to develop future vaccines that could come in the form of a patch or a pill.
FDA expected to approve vaccine for adolescents
The FDA could soon approve its first coronavirus vaccine for kids as young as 12 years old. As CBS News' Mola Lenghi reports, children now make up nearly a fourth all new cases in the U.S. Then Dr. Payal Patel, an infectious diseases physician at the University of Michigan Medical School, joins CBSN's Elaine Quijano to discuss the latest COVID headlines.
Pfizer seeking vaccine authorization for adolescents
The FDA is expected to authorize Pfizer-BioNTech's COVID-19 vaccine for administration to adolescents by early next week. The company is also preparing to seek full FDA approval — not just emergency authorization — for adults. Mola Lenghi reports.
COVID vaccine could be authorized for adolescents by early next week
A federal official confirmed the FDA is expected to authorize Pfizer's COVID-19 vaccine for children as young as 12 years of age.
FDA expected to OK vaccine for kids 12 and up
CBS News has learned the Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for children as young as 12 as soon as next week. Meanwhile, as states and cities continue to reopen, a variant in Oregon has led to one of the largest increases in infections in the country. CBS News correspondent Laura Podesta joins CBSN AM with the latest.
Pfizer vaccine could soon be approved for adolescents
The Food and Drug Administration could approve Pfizer's COVID-19 vaccine for children ages 12 to 15 as early as next week. Dr. Julie Morita, a pediatrician and the executive vice president of the Robert Wood Johnson Foundation, joined CBSN's Tanya Rivero with more on how this could impact herd immunity.
FDA may allow Pfizer vaccine for adolescents
The Food and Drug Administration is expected to expand the authorization for Pfizer's coronavirus vaccine to children ages 12 to 15 in the coming days. The CDC's Advisory Committee on Vaccination Practices would also need to update its recommendations for the shot. Dr. Dyan Hes, founder of Gramercy Pediatrics in New York City, joined CBSN to discuss the next steps in the vaccination effort.
Pfizer authorization imminent for adolescents
A federal health official tells CBS News the FDA is expected to authorize emergency use of Pfizer's coronavirus vaccine for adolescents aged 12 to 15 years old, as soon as this week. This comes as many health experts are warning that vaccine hesitancy and new COVID variants could prevent the U.S. from reaching widespread or "herd" immunity. Dr. Ashish Jha joins "CBS This Morning" to discuss the imminent Pfizer EUA for adolescents and the herd immunity debate.
FDA expected to approve vaccine for some kids
The FDA is expected to approve Pfizer's vaccine for children aged 12 to 15 year old as early as the end of this week. This comes as New York, Connecticut and New Jersey all announced they would lift most capacity limits on May 19. Mola Lenghi reports.
Developing the Pfizer-BioNTech COVID vaccine
Bill Whitaker reports on the scientists and advances in biotechnology behind a COVID-19 vaccine that could help end the pandemic.
New York City makes plans to fully reopen
New York City officials are coming up with plans to fully reopen this summer. As CBS News' Nikki Battiste reports, the good news comes as coronavirus vaccinations decline and millions in the Pacific Northwest face new restrictions. Then, Dr. Amesh Adalja, an infectious disease expert and senior scholar at John's Hopkins University's Bloomberg School of Public Medicine, joins CBSN's Elaine Quijano with his analysis.
1,300 vaccine doses set to go to waste in Philadelphia
Supply of the vaccine is outpacing demand in parts of the U.S. as some Americans remain reluctant to get shots.
1,000 vaccine doses could expire
More than 1,000 doses of Pfizer's COVID-19 vaccine could go to waste in Philadelphia if they're not used today, as the rate of vaccination slows in the U.S. and supply starts to outpace demand in some areas. CBSN's Vladimir Duthiers and Anne-Marie Green have more.
COVID-19 pill could be ready by year's end, Pfizer CEO says
Vaccine maker chief tells CNBC that oral drug to fight the coronavirus early on could be available later this year.
Millions of Americans missed 2nd COVID vaccine appointment
According to the CDC, more than five million people, or about 8%, had missed their second Pfizer or Moderna doses as of early April.
Study: COVID vaccines safe during pregnancy
New research published by the Centers for Disease Control and Prevention says there is no evidence showing that Pfizer or Moderna's coronavirus vaccines pose risk during pregnancy. CBS News reporter Alex Tin joins CBSN's "Red & Blue" with more on the study and an update on when health officials might end the pause on Johnson & Johnson's vaccine.
New York City opens all city-run vaccination sites to walk-ins
"This is what will bring us forward," Mayor Bill de Blasio said Friday. "This is what will create a recovery for all of us."
Moderna, Pfizer vaccines safe during pregnancy, study finds
The preliminary study adds to a growing body of research that suggests the COVID-19 vaccine is safe during pregnancy.
COVID-19 vaccine efforts face new challenges
The U.S. will soon hit President Biden's goal of administering 200 million COVID vaccine doses in his first 100 days in office. But the milestone comes amid reports of a recent 11% decrease in the number of shots given over the past week. Dr. Eric Cioe-Peña, an emergency room physician and director of global health at Northwell Health, joined CBSN to discuss the country's vaccine efforts.
Wells Fargo CEO's platinum 'chute, and other MoneyWatch headlines
Wells Fargo chief could leave with $200M; Pfizer opts against break-up; and Iran brings back the credit card. These headlines and more from CBS MoneyWatch.
Pfizer warns of phony COVID-19 vaccines outside the U.S.
Strong global demand for COVID-19 vaccines is creating fertile ground for criminal schemes, health officials say.
8/22 Moneywatch
Pfizer buying prostate cancer specialist Medivation for $14B; ex-NBA star Kobe Bryant to launch venture capital fund; and heavy flooding threatens U.S. rice harvest. These headlines and more from CBS MoneyWatch.
Study shows vaccines carry much lower risk of blood clots than COVID
Research by Oxford University suggests all major vaccines carry a similar risk of rare clots, and all seem to have much lower risk than infection with COVID-19.
Jane Doe's attorney says "she was incapable of consent," alleges cover-up
Christa Pike critically ill, intubated after botched execution, attorneys say
More details emerge about FlyDubai co-pilot who tried to crash plane
Live
Trump vows Iran war to end "very quickly" as more troops head to Mideast
Judge says federal law banning noncitizen voting is unconstitutional
Professor to present findings questioning whether Epstein killed himself
Trump says Europe will release "massive amount" of diesel oil from stockpiles
Photo of Jane Doe shared in Snapchat group on night of alleged rape
